Activation of platelets by modified C-reactive protein

Area of Science:

• Immunology
• Hematology
• Biochemistry

Background:

• C-reactive protein (CRP) shares functional similarities with immunoglobulin.
• The potential for modified CRP to activate platelets, analogous to immunoglobulin, was investigated.

Purpose of the Study:

• To determine if modified C-reactive protein (CRP) can activate human platelets.
• To compare the platelet-activating effects of modified CRP with those of aggregated immunoglobulin.

Main Methods:

• Thermally-aggregated CRP (H-CRP) was used to stimulate isolated human platelets.
• Platelet aggregation, secretion, and activation pathways were analyzed.
• The effects of ligands complexed with CRP were also assessed.

Main Results:

• Thermally-aggregated CRP (H-CRP), but not unmodified CRP, induced platelet aggregation and secretion.
• H-CRP was more potent than aggregated human IgG (AHGG) in activating platelets.
• CRP-ligand complexes with polycations (PLL, protamine) activated platelets, unlike CRP-CPS complexes.

Conclusions:

• Appropriately modified CRP can stimulate or enhance human platelet responsiveness.
• CRP's ability to activate platelets supports its role in initiating biological activities akin to immunoglobulin.
• These findings suggest CRP acts as a crucial link in immune responses, interacting with various immune cells and systems.